(Oct. 12, 2011) – A nutritional supplement in capsule form used by bodybuilders as an aid to increasing muscle mass has been pulled from shelves after the U.S. Food & Drug Administration found the product contained a banned synthetic anabolic steroid, superdrol.
Uprizing 2.0 maker Superior Metabolic Technologies in August received a letter of notification from the FDA informing the Marietta, Ga., company of the formulation problem.
Superior Metabolic Technologies responded by voluntarily removing superdrol-containing Uprizing 2.0 from the market. Uprizing 2.0 was sold through retail health-food stores in Alabama, Arizona, California, Georgia, Mississippi, New Jersey, South Carolina, and Texas, but also worldwide through online distributors.
According to the FDA, acute liver injury is a known possible harmful effect of using products containing synthetic anabolic steroids, such as superdrol.
“…[S]ynthetic anabolic steroids may cause…shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher predilection to mis-use other drugs and alcohol, adverse effects on blood lipid levels, and increased risk of heart attack, stroke, and death,” the FDA said.
The FDA advises consumers who purchased Uprizing 2.0 to return it to the place of purchase. Side-effects or adverse health events suspected as being related to the taking of the ingredient superdrol should be reported to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program, the agency said.